date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.358793640571792.
The log-likelihood improved by 3.46.
Iteration 2 of at most 500:
Optimizing with step length 0.563356882493404.
The log-likelihood improved by 2.236.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 2.059.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1376.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       3       20     1233      951      782      347      400      384 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     317      234      145       85       51       28       11        7 
degree16 
       2 
1 
disease_progression 
H-positive risk:  841 897 133 888 438 129 855 428 136 69 126 60 
H-negative risk:  897 841 855 888 428 438 129 133 126 136 60 69 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
52 new agents 
2 
disease_progression 
H-positive risk:  843 900 134 885 433 128 858 426 135 69 127 62 
H-negative risk:  900 843 858 885 426 433 128 134 127 135 62 69 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
63 new agents 
3 
disease_progression 
H-positive risk:  847 904 134 886 429 129 863 418 135 68 125 62 
H-negative risk:  904 847 863 886 418 429 129 134 125 135 62 68 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 5 

clinical_engagement 
diagnosis 
demography 
78 new agents 
4 
disease_progression 
H-positive risk:  857 908 135 888 419 129 863 416 132 68 126 59 
H-negative risk:  908 857 863 888 416 419 129 135 126 132 59 68 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 7 

clinical_engagement 
diagnosis 
demography 
61 new agents 
5 
disease_progression 
H-positive risk:  869 910 135 894 407 129 860 415 131 65 126 59 
H-negative risk:  910 869 860 894 415 407 129 135 126 131 59 65 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 10 

clinical_engagement 
diagnosis 
demography 
64 new agents 
6 
disease_progression 
H-positive risk:  878 914 135 900 403 130 859 405 129 65 123 59 
H-negative risk:  914 878 859 900 405 403 130 135 123 129 59 65 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
7 
disease_progression 
H-positive risk:  885 922 134 901 399 130 856 396 131 64 122 60 
H-negative risk:  922 885 856 901 396 399 130 134 122 131 60 64 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 13 

clinical_engagement 
diagnosis 
demography 
50 new agents 
8 
disease_progression 
H-positive risk:  891 923 135 904 398 129 854 389 134 65 121 57 
H-negative risk:  923 891 854 904 389 398 129 135 121 134 57 65 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 14 3 

clinical_engagement 
diagnosis 
demography 
57 new agents 
9 
disease_progression 
H-positive risk:  890 922 135 902 397 131 858 390 134 63 120 58 
H-negative risk:  922 890 858 902 390 397 131 135 120 134 58 63 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 16 4 

clinical_engagement 
diagnosis 
demography 
50 new agents 
10 
disease_progression 
H-positive risk:  895 923 137 898 394 133 859 390 133 60 120 58 
H-negative risk:  923 895 859 898 390 394 133 137 120 133 58 60 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 18 4 

clinical_engagement 
diagnosis 
demography 
48 new agents 
11 
disease_progression 
H-positive risk:  895 928 136 896 390 134 857 386 137 58 124 59 
H-negative risk:  928 895 857 896 386 390 134 136 124 137 59 58 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 21 4 

clinical_engagement 
diagnosis 
demography 
49 new agents 
12 
disease_progression 
H-positive risk:  896 930 140 893 387 133 861 382 138 59 125 56 
H-negative risk:  930 896 861 893 382 387 133 140 125 138 56 59 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 23 4 

clinical_engagement 
diagnosis 
demography 
70 new agents 
13 
disease_progression 
H-positive risk:  836 861 131 970 378 119 929 372 153 57 135 59 
H-negative risk:  861 836 929 970 372 378 119 131 135 153 59 57 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 24 4 

clinical_engagement 
diagnosis 
demography 
194 new agents 
14 
disease_progression 
H-positive risk:  857 887 135 941 392 124 880 387 134 70 123 70 
H-negative risk:  887 857 880 941 387 392 124 135 123 134 70 70 
New BC onsets:  27
BC status:  4973 27 
BC subtype:  4973 23 4 

clinical_engagement 
diagnosis 
demography 
60 new agents 
15 
disease_progression 
H-positive risk:  855 896 136 933 391 125 887 379 134 71 123 70 
H-negative risk:  896 855 887 933 379 391 125 136 123 134 70 71 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 25 3 

clinical_engagement 
diagnosis 
demography 
59 new agents 
16 
disease_progression 
H-positive risk:  861 900 138 929 388 125 883 379 134 72 121 70 
H-negative risk:  900 861 883 929 379 388 125 138 121 134 70 72 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 27 3 

clinical_engagement 
diagnosis 
demography 
71 new agents 
17 
disease_progression 
H-positive risk:  865 905 140 923 384 126 878 383 131 75 121 69 
H-negative risk:  905 865 878 923 383 384 126 140 121 131 69 75 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 28 3 

clinical_engagement 
diagnosis 
demography 
67 new agents 
18 
disease_progression 
H-positive risk:  871 909 141 923 383 125 875 377 133 74 121 68 
H-negative risk:  909 871 875 923 377 383 125 141 121 133 68 74 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 30 3 

clinical_engagement 
diagnosis 
demography 
70 new agents 
19 
disease_progression 
H-positive risk:  878 904 140 918 379 127 884 378 130 73 120 69 
H-negative risk:  904 878 884 918 378 379 127 140 120 130 69 73 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 32 3 

clinical_engagement 
diagnosis 
demography 
71 new agents 
20 
disease_progression 
H-positive risk:  880 906 145 916 376 128 881 376 131 75 117 69 
H-negative risk:  906 880 881 916 376 376 128 145 117 131 69 75 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 34 3 

clinical_engagement 
diagnosis 
demography 
75 new agents 
21 
disease_progression 
H-positive risk:  882 901 145 919 378 129 886 372 130 72 117 69 
H-negative risk:  901 882 886 919 372 378 129 145 117 130 69 72 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 36 5 

clinical_engagement 
diagnosis 
demography 
71 new agents 
22 
disease_progression 
H-positive risk:  884 906 143 914 377 131 888 367 132 73 118 67 
H-negative risk:  906 884 888 914 367 377 131 143 118 132 67 73 
New BC onsets:  43
BC status:  4957 43 
BC subtype:  4957 38 5 

clinical_engagement 
diagnosis 
demography 
67 new agents 
23 
disease_progression 
H-positive risk:  889 907 144 910 373 135 896 361 129 71 119 66 
H-negative risk:  907 889 896 910 361 373 135 144 119 129 66 71 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 39 5 

clinical_engagement 
diagnosis 
demography 
52 new agents 
24 
disease_progression 
H-positive risk:  892 914 145 904 369 135 899 358 128 70 119 67 
H-negative risk:  914 892 899 904 358 369 135 145 119 128 67 70 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 42 5 

clinical_engagement 
diagnosis 
demography 
55 new agents 
25 
disease_progression 
H-positive risk:  829 854 130 965 373 127 962 357 136 67 132 68 
H-negative risk:  854 829 962 965 357 373 127 130 132 136 68 67 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 42 5 

clinical_engagement 
diagnosis 
demography 
189 new agents 
26 
disease_progression 
H-positive risk:  847 873 137 911 395 130 939 369 131 71 124 73 
H-negative risk:  873 847 939 911 369 395 130 137 124 131 73 71 
New BC onsets:  50
BC status:  4950 50 
BC subtype:  4950 45 5 

clinical_engagement 
diagnosis 
demography 
70 new agents 
27 
disease_progression 
H-positive risk:  858 875 138 909 392 131 929 376 130 71 120 71 
H-negative risk:  875 858 929 909 376 392 131 138 120 130 71 71 
New BC onsets:  52
BC status:  4948 52 
BC subtype:  4948 47 5 

clinical_engagement 
diagnosis 
demography 
66 new agents 
28 
disease_progression 
H-positive risk:  858 885 139 903 394 129 932 372 129 70 119 70 
H-negative risk:  885 858 932 903 372 394 129 139 119 129 70 70 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 47 6 

clinical_engagement 
diagnosis 
demography 
64 new agents 
29 
disease_progression 
H-positive risk:  857 887 136 911 383 129 939 370 132 68 118 70 
H-negative risk:  887 857 939 911 370 383 129 136 118 132 70 68 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 49 6 

clinical_engagement 
diagnosis 
demography 
74 new agents 
30 
disease_progression 
H-positive risk:  864 892 137 908 384 126 937 365 132 67 120 68 
H-negative risk:  892 864 937 908 365 384 126 137 120 132 68 67 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 47 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
31 
disease_progression 
H-positive risk:  865 890 140 911 380 127 935 367 130 68 120 67 
H-negative risk:  890 865 935 911 367 380 127 140 120 130 67 68 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 47 6 

clinical_engagement 
diagnosis 
demography 
67 new agents 
32 
disease_progression 
H-positive risk:  877 892 138 912 369 128 933 365 131 69 120 66 
H-negative risk:  892 877 933 912 365 369 128 138 120 131 66 69 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 50 6 

clinical_engagement 
diagnosis 
demography 
55 new agents 
33 
disease_progression 
H-positive risk:  882 893 135 914 369 129 930 361 134 70 118 65 
H-negative risk:  893 882 930 914 361 369 129 135 118 134 65 70 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 51 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
34 
disease_progression 
H-positive risk:  888 897 137 908 362 131 938 354 134 71 116 64 
H-negative risk:  897 888 938 908 354 362 131 137 116 134 64 71 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 54 8 

clinical_engagement 
diagnosis 
demography 
68 new agents 
35 
disease_progression 
H-positive risk:  889 905 137 901 360 133 934 355 136 70 117 63 
H-negative risk:  905 889 934 901 355 360 133 137 117 136 63 70 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 55 8 

clinical_engagement 
diagnosis 
demography 
45 new agents 
36 
disease_progression 
H-positive risk:  892 908 137 900 359 134 933 354 133 71 114 65 
H-negative risk:  908 892 933 900 354 359 134 137 114 133 65 71 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 54 7 

clinical_engagement 
diagnosis 
demography 
72 new agents 
37 
disease_progression 
H-positive risk:  832 840 127 977 361 128 981 355 140 74 124 61 
H-negative risk:  840 832 981 977 355 361 128 127 124 140 61 74 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 53 9 

clinical_engagement 
diagnosis 
demography 
145 new agents 
38 
disease_progression 
H-positive risk:  838 843 128 942 397 131 954 376 135 74 119 63 
H-negative risk:  843 838 954 942 376 397 131 128 119 135 63 74 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 54 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
39 
disease_progression 
H-positive risk:  840 847 126 933 397 132 959 375 137 73 118 63 
H-negative risk:  847 840 959 933 375 397 132 126 118 137 63 73 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 54 11 

clinical_engagement 
diagnosis 
demography 
63 new agents 
40 
disease_progression 
H-positive risk:  842 851 125 931 401 132 951 373 141 72 118 63 
H-negative risk:  851 842 951 931 373 401 132 125 118 141 63 72 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 56 11 

clinical_engagement 
diagnosis 
demography 
82 new agents 
41 
disease_progression 
H-positive risk:  850 855 126 920 401 132 945 377 142 70 119 63 
H-negative risk:  855 850 945 920 377 401 132 126 119 142 63 70 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 56 11 

clinical_engagement 
diagnosis 
demography 
61 new agents 
42 
disease_progression 
H-positive risk:  852 857 129 922 396 130 946 375 141 68 121 63 
H-negative risk:  857 852 946 922 375 396 130 129 121 141 63 68 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 58 11 

clinical_engagement 
diagnosis 
demography 
67 new agents 
43 
disease_progression 
H-positive risk:  861 860 130 914 396 130 943 377 139 67 118 65 
H-negative risk:  860 861 943 914 377 396 130 130 118 139 65 67 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 56 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
44 
disease_progression 
H-positive risk:  864 852 132 923 398 128 939 377 140 67 115 65 
H-negative risk:  852 864 939 923 377 398 128 132 115 140 65 67 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 57 11 

clinical_engagement 
diagnosis 
demography 
53 new agents 
45 
disease_progression 
H-positive risk:  862 863 133 922 401 127 936 373 138 66 116 63 
H-negative risk:  863 862 936 922 373 401 127 133 116 138 63 66 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 56 12 

clinical_engagement 
diagnosis 
demography 
82 new agents 
46 
disease_progression 
H-positive risk:  869 873 131 922 390 131 935 374 138 64 113 60 
H-negative risk:  873 869 935 922 374 390 131 131 113 138 60 64 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 55 14 

clinical_engagement 
diagnosis 
demography 
66 new agents 
47 
disease_progression 
H-positive risk:  882 868 132 929 388 131 935 369 135 64 107 60 
H-negative risk:  868 882 935 929 369 388 131 132 107 135 60 64 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 54 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
48 
disease_progression 
H-positive risk:  887 869 130 931 383 132 932 374 132 62 110 58 
H-negative risk:  869 887 932 931 374 383 132 130 110 132 58 62 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 57 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
49 
disease_progression 
H-positive risk:  819 804 123 1007 371 124 999 376 141 60 118 58 
H-negative risk:  804 819 999 1007 376 371 124 123 118 141 58 60 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 57 17 

clinical_engagement 
diagnosis 
demography 
146 new agents 
50 
disease_progression 
H-positive risk:  827 814 121 976 389 129 987 376 141 60 121 59 
H-negative risk:  814 827 987 976 376 389 129 121 121 141 59 60 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 57 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
51 
disease_progression 
H-positive risk:  832 810 124 975 391 126 987 381 141 59 120 54 
H-negative risk:  810 832 987 975 381 391 126 124 120 141 54 59 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 55 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
52 
disease_progression 
H-positive risk:  829 812 126 971 381 127 999 383 139 59 120 54 
H-negative risk:  812 829 999 971 383 381 127 126 120 139 54 59 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
53 
disease_progression 
H-positive risk:  827 815 127 967 378 127 1002 387 139 59 119 53 
H-negative risk:  815 827 1002 967 387 378 127 127 119 139 53 59 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
54 
disease_progression 
H-positive risk:  833 818 127 966 378 131 993 388 136 62 119 49 
H-negative risk:  818 833 993 966 388 378 131 127 119 136 49 62 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
55 
disease_progression 
H-positive risk:  841 827 124 964 377 130 976 391 137 61 122 50 
H-negative risk:  827 841 976 964 391 377 130 124 122 137 50 61 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 51 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
56 
disease_progression 
H-positive risk:  834 835 123 964 370 131 984 386 134 62 125 52 
H-negative risk:  835 834 984 964 386 370 131 123 125 134 52 62 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
57 
disease_progression 
H-positive risk:  836 835 124 958 370 132 981 393 134 61 123 53 
H-negative risk:  835 836 981 958 393 370 132 124 123 134 53 61 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 53 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
58 
disease_progression 
H-positive risk:  838 837 123 955 365 138 986 384 138 58 124 54 
H-negative risk:  837 838 986 955 384 365 138 123 124 138 54 58 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
62 new agents 
59 
disease_progression 
H-positive risk:  835 846 123 949 363 136 994 380 138 60 125 51 
H-negative risk:  846 835 994 949 380 363 136 123 125 138 51 60 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
60 
disease_progression 
H-positive risk:  842 852 124 947 362 133 991 373 136 60 126 54 
H-negative risk:  852 842 991 947 373 362 133 124 126 136 54 60 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
61 
disease_progression 
H-positive risk:  784 791 116 1013 362 120 1046 368 147 63 133 57 
H-negative risk:  791 784 1046 1013 368 362 120 116 133 147 57 63 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 52 20 

clinical_engagement 
diagnosis 
demography 
114 new agents 
62 
disease_progression 
H-positive risk:  779 790 125 980 390 124 1016 398 146 63 129 60 
H-negative risk:  790 779 1016 980 398 390 124 125 129 146 60 63 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 52 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
63 
disease_progression 
H-positive risk:  780 799 126 976 389 123 1011 396 143 66 131 60 
H-negative risk:  799 780 1011 976 396 389 123 126 131 143 60 66 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 52 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
64 
disease_progression 
H-positive risk:  783 796 126 974 389 124 1013 391 147 67 131 59 
H-negative risk:  796 783 1013 974 391 389 124 126 131 147 59 67 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 54 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
65 
disease_progression 
H-positive risk:  783 797 128 980 387 121 1013 388 147 66 130 60 
H-negative risk:  797 783 1013 980 388 387 121 128 130 147 60 66 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 54 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
66 
disease_progression 
H-positive risk:  787 793 130 980 387 121 1019 383 146 64 130 60 
H-negative risk:  793 787 1019 980 383 387 121 130 130 146 60 64 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
67 
disease_progression 
H-positive risk:  785 793 130 974 390 121 1023 385 145 64 129 61 
H-negative risk:  793 785 1023 974 385 390 121 130 129 145 61 64 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 55 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
68 
disease_progression 
H-positive risk:  787 795 128 981 387 121 1026 380 139 64 132 60 
H-negative risk:  795 787 1026 981 380 387 121 128 132 139 60 64 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 57 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
69 
disease_progression 
H-positive risk:  794 799 129 983 382 122 1019 380 137 62 133 60 
H-negative risk:  799 794 1019 983 380 382 122 129 133 137 60 62 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 59 26 

clinical_engagement 
diagnosis 
demography 
62 new agents 
70 
disease_progression 
H-positive risk:  790 802 127 983 381 120 1023 385 136 63 132 58 
H-negative risk:  802 790 1023 983 385 381 120 127 132 136 58 63 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
71 
disease_progression 
H-positive risk:  781 802 129 989 381 121 1025 384 138 60 133 57 
H-negative risk:  802 781 1025 989 384 381 121 129 133 138 57 60 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 60 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
72 
disease_progression 
H-positive risk:  787 796 128 996 383 121 1019 384 135 59 135 57 
H-negative risk:  796 787 1019 996 384 383 121 128 135 135 57 59 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 59 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
73 
disease_progression 
H-positive risk:  752 759 124 1046 373 111 1060 376 145 58 138 58 
H-negative risk:  759 752 1060 1046 376 373 111 124 138 145 58 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 60 24 

clinical_engagement 
diagnosis 
demography 
113 new agents 
74 
disease_progression 
H-positive risk:  755 766 125 1024 395 113 1040 392 138 56 140 56 
H-negative risk:  766 755 1040 1024 392 395 113 125 140 138 56 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 65 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
75 
disease_progression 
H-positive risk:  756 776 125 1031 384 114 1033 390 137 57 139 58 
H-negative risk:  776 756 1033 1031 390 384 114 125 139 137 58 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
76 
disease_progression 
H-positive risk:  757 769 121 1053 381 114 1025 391 134 57 140 58 
H-negative risk:  769 757 1025 1053 391 381 114 121 140 134 58 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
77 
disease_progression 
H-positive risk:  757 765 120 1048 383 115 1030 388 133 59 142 60 
H-negative risk:  765 757 1030 1048 388 383 115 120 142 133 60 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 64 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
78 
disease_progression 
H-positive risk:  754 765 121 1048 377 115 1037 388 133 62 142 58 
H-negative risk:  765 754 1037 1048 388 377 115 121 142 133 58 62 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 65 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
79 
disease_progression 
H-positive risk:  760 769 123 1041 384 115 1032 382 132 61 144 57 
H-negative risk:  769 760 1032 1041 382 384 115 123 144 132 57 61 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 63 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
80 
disease_progression 
H-positive risk:  755 767 124 1044 386 114 1024 388 133 62 145 58 
H-negative risk:  767 755 1024 1044 388 386 114 124 145 133 58 62 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 62 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
81 
disease_progression 
H-positive risk:  758 771 121 1043 386 113 1023 391 128 62 148 56 
H-negative risk:  771 758 1023 1043 391 386 113 121 148 128 56 62 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 65 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
82 
disease_progression 
H-positive risk:  761 768 122 1047 381 113 1024 393 127 61 149 54 
H-negative risk:  768 761 1024 1047 393 381 113 122 149 127 54 61 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 65 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
83 
disease_progression 
H-positive risk:  755 773 121 1050 385 110 1018 397 127 59 151 54 
H-negative risk:  773 755 1018 1050 397 385 110 121 151 127 54 59 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
84 
disease_progression 
H-positive risk:  759 772 123 1057 381 109 1007 401 128 59 152 52 
H-negative risk:  772 759 1007 1057 401 381 109 123 152 128 52 59 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 61 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
85 
disease_progression 
H-positive risk:  719 735 116 1093 387 99 1043 395 140 57 163 53 
H-negative risk:  735 719 1043 1093 395 387 99 116 163 140 53 57 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 64 15 

clinical_engagement 
diagnosis 
demography 
101 new agents 
86 
disease_progression 
H-positive risk:  735 731 118 1086 400 97 1001 421 139 53 166 53 
H-negative risk:  731 735 1001 1086 421 400 97 118 166 139 53 53 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 66 17 

clinical_engagement 
diagnosis 
demography 
108 new agents 
87 
disease_progression 
H-positive risk:  737 738 116 1083 399 98 993 421 138 54 169 54 
H-negative risk:  738 737 993 1083 421 399 98 116 169 138 54 54 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 67 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
88 
disease_progression 
H-positive risk:  738 738 117 1089 400 101 991 411 136 55 170 54 
H-negative risk:  738 738 991 1089 411 400 101 117 170 136 54 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 67 23 

clinical_engagement 
diagnosis 
demography 
52 new agents 
89 
disease_progression 
H-positive risk:  737 738 119 1079 404 101 999 410 137 55 168 53 
H-negative risk:  738 737 999 1079 410 404 101 119 168 137 53 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
90 
disease_progression 
H-positive risk:  735 737 121 1074 406 104 1005 403 136 59 167 53 
H-negative risk:  737 735 1005 1074 403 406 104 121 167 136 53 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
91 
disease_progression 
H-positive risk:  735 737 122 1073 409 103 1002 400 138 58 168 55 
H-negative risk:  737 735 1002 1073 400 409 103 122 168 138 55 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
92 
disease_progression 
H-positive risk:  736 733 121 1074 410 103 1003 400 139 59 169 53 
H-negative risk:  733 736 1003 1074 400 410 103 121 169 139 53 59 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 69 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
93 
disease_progression 
H-positive risk:  728 733 120 1074 410 106 1021 393 138 57 169 51 
H-negative risk:  733 728 1021 1074 393 410 106 120 169 138 51 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
94 
disease_progression 
H-positive risk:  727 740 118 1064 415 103 1021 388 139 60 173 52 
H-negative risk:  740 727 1021 1064 388 415 103 118 173 139 52 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
95 
disease_progression 
H-positive risk:  740 738 114 1060 416 104 1017 387 138 59 175 52 
H-negative risk:  738 740 1017 1060 387 416 104 114 175 138 52 59 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
96 
disease_progression 
H-positive risk:  742 741 115 1060 416 100 1024 375 141 58 174 54 
H-negative risk:  741 742 1024 1060 375 416 100 115 174 141 54 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
97 
disease_progression 
H-positive risk:  700 703 108 1096 406 100 1072 372 144 60 184 55 
H-negative risk:  703 700 1072 1096 372 406 100 108 184 144 55 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
109 new agents 
98 
disease_progression 
H-positive risk:  701 701 113 1088 412 99 1062 382 146 57 182 57 
H-negative risk:  701 701 1062 1088 382 412 99 113 182 146 57 57 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
99 
disease_progression 
H-positive risk:  714 701 114 1086 407 100 1061 383 144 53 180 57 
H-negative risk:  701 714 1061 1086 383 407 100 114 180 144 57 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
100 
disease_progression 
H-positive risk:  721 703 111 1081 408 101 1061 382 137 54 185 56 
H-negative risk:  703 721 1061 1081 382 408 101 111 185 137 56 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
101 
disease_progression 
H-positive risk:  720 697 107 1089 411 100 1057 379 143 54 184 59 
H-negative risk:  697 720 1057 1089 379 411 100 107 184 143 59 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
102 
disease_progression 
H-positive risk:  722 697 107 1089 410 102 1056 378 140 54 183 62 
H-negative risk:  697 722 1056 1089 378 410 102 107 183 140 62 54 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
103 
disease_progression 
H-positive risk:  725 689 106 1093 402 103 1073 375 138 51 179 66 
H-negative risk:  689 725 1073 1093 375 402 103 106 179 138 66 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
54 new agents 
104 
disease_progression 
H-positive risk:  734 688 106 1090 392 103 1079 371 137 52 181 67 
H-negative risk:  688 734 1079 1090 371 392 103 106 181 137 67 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
105 
disease_progression 
H-positive risk:  736 689 107 1091 395 101 1079 366 136 52 180 68 
H-negative risk:  689 736 1079 1091 366 395 101 107 180 136 68 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
106 
disease_progression 
H-positive risk:  733 691 108 1084 399 100 1084 364 136 52 179 70 
H-negative risk:  691 733 1084 1084 364 399 100 108 179 136 70 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
107 
disease_progression 
H-positive risk:  735 692 109 1090 403 103 1084 353 137 49 175 70 
H-negative risk:  692 735 1084 1090 353 403 103 109 175 137 70 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
108 
disease_progression 
H-positive risk:  735 693 107 1077 412 102 1090 355 135 49 175 70 
H-negative risk:  693 735 1090 1077 355 412 102 107 175 135 70 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
109 
disease_progression 
H-positive risk:  694 653 97 1117 409 98 1140 351 140 47 184 70 
H-negative risk:  653 694 1140 1117 351 409 98 97 184 140 70 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
116 new agents 
110 
disease_progression 
H-positive risk:  706 655 95 1104 419 99 1119 368 131 51 185 68 
H-negative risk:  655 706 1119 1104 368 419 99 95 185 131 68 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
91 new agents 
111 
disease_progression 
H-positive risk:  703 665 97 1093 422 102 1123 363 131 51 183 67 
H-negative risk:  665 703 1123 1093 363 422 102 97 183 131 67 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
112 
disease_progression 
H-positive risk:  707 673 97 1093 414 100 1119 363 129 52 185 68 
H-negative risk:  673 707 1119 1093 363 414 100 97 185 129 68 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
57 new agents 
113 
disease_progression 
H-positive risk:  704 667 97 1094 421 101 1119 364 129 50 186 68 
H-negative risk:  667 704 1119 1094 364 421 101 97 186 129 68 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
95 new agents 
114 
disease_progression 
H-positive risk:  707 665 96 1091 421 99 1118 362 132 48 190 71 
H-negative risk:  665 707 1118 1091 362 421 99 96 190 132 71 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
115 
disease_progression 
H-positive risk:  705 665 98 1087 422 99 1116 367 133 48 189 71 
H-negative risk:  665 705 1116 1087 367 422 99 98 189 133 71 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
116 
disease_progression 
H-positive risk:  698 664 101 1088 422 98 1119 367 138 46 188 71 
H-negative risk:  664 698 1119 1088 367 422 98 101 188 138 71 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
117 
disease_progression 
H-positive risk:  706 662 102 1085 427 98 1114 365 136 47 187 71 
H-negative risk:  662 706 1114 1085 365 427 98 102 187 136 71 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
118 
disease_progression 
H-positive risk:  704 667 104 1089 428 94 1108 364 138 50 183 71 
H-negative risk:  667 704 1108 1089 364 428 94 104 183 138 71 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
77 new agents 
119 
disease_progression 
H-positive risk:  709 671 105 1096 427 94 1093 366 138 50 180 71 
H-negative risk:  671 709 1093 1096 366 427 94 105 180 138 71 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
120 
disease_progression 
H-positive risk:  715 671 105 1092 423 96 1090 365 137 52 183 71 
H-negative risk:  671 715 1090 1092 365 423 96 105 183 137 71 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
121 
disease_progression 
H-positive risk:  676 629 98 1140 418 90 1130 366 141 53 190 69 
H-negative risk:  629 676 1130 1140 366 418 90 98 190 141 69 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
122 
disease_progression 
H-positive risk:  677 639 97 1135 420 87 1124 367 139 56 188 71 
H-negative risk:  639 677 1124 1135 367 420 87 97 188 139 71 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
101 new agents 
123 
disease_progression 
H-positive risk:  689 635 98 1141 420 83 1108 374 137 57 184 74 
H-negative risk:  635 689 1108 1141 374 420 83 98 184 137 74 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
124 
disease_progression 
H-positive risk:  690 640 98 1139 418 84 1110 377 134 53 182 75 
H-negative risk:  640 690 1110 1139 377 418 84 98 182 134 75 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 74 33 

clinical_engagement 
diagnosis 
demography 
70 new agents 
125 
disease_progression 
H-positive risk:  690 642 101 1138 421 83 1104 380 138 52 177 74 
H-negative risk:  642 690 1104 1138 380 421 83 101 177 138 74 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
126 
disease_progression 
H-positive risk:  696 646 99 1133 409 81 1112 381 137 51 181 74 
H-negative risk:  646 696 1112 1133 381 409 81 99 181 137 74 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
74 new agents 
127 
disease_progression 
H-positive risk:  693 648 101 1124 408 84 1120 385 136 50 180 71 
H-negative risk:  648 693 1120 1124 385 408 84 101 180 136 71 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
60 new agents 
128 
disease_progression 
H-positive risk:  693 642 98 1124 408 86 1124 381 137 53 181 73 
H-negative risk:  642 693 1124 1124 381 408 86 98 181 137 73 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
129 
disease_progression 
H-positive risk:  699 644 99 1123 409 88 1117 380 136 52 181 72 
H-negative risk:  644 699 1117 1123 380 409 88 99 181 136 72 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 70 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
130 
disease_progression 
H-positive risk:  703 644 98 1132 405 85 1110 383 137 52 181 70 
H-negative risk:  644 703 1110 1132 383 405 85 98 181 137 70 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
131 
disease_progression 
H-positive risk:  695 647 95 1133 399 82 1118 392 143 48 179 69 
H-negative risk:  647 695 1118 1133 392 399 82 95 179 143 69 48 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
132 
disease_progression 
H-positive risk:  684 656 94 1134 396 84 1124 395 141 49 176 67 
H-negative risk:  656 684 1124 1134 395 396 84 94 176 141 67 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
133 
disease_progression 
H-positive risk:  689 654 92 1134 400 84 1120 393 142 48 178 66 
H-negative risk:  654 689 1120 1134 393 400 84 92 178 142 66 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
112 new agents 
134 
disease_progression 
H-positive risk:  691 657 88 1133 400 83 1121 390 137 48 184 68 
H-negative risk:  657 691 1121 1133 390 400 83 88 184 137 68 48 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
93 new agents 
135 
disease_progression 
H-positive risk:  692 648 88 1149 393 86 1117 390 136 49 181 71 
H-negative risk:  648 692 1117 1149 390 393 86 88 181 136 71 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
87 new agents 
136 
disease_progression 
H-positive risk:  683 651 88 1156 390 85 1127 391 135 46 180 68 
H-negative risk:  651 683 1127 1156 391 390 85 88 180 135 68 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
137 
disease_progression 
H-positive risk:  695 643 89 1163 388 87 1124 385 133 44 181 68 
H-negative risk:  643 695 1124 1163 385 388 87 89 181 133 68 44 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
138 
disease_progression 
H-positive risk:  694 645 87 1161 392 88 1126 385 129 45 181 67 
H-negative risk:  645 694 1126 1161 385 392 88 87 181 129 67 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
139 
disease_progression 
H-positive risk:  691 646 83 1164 399 88 1118 386 131 47 183 64 
H-negative risk:  646 691 1118 1164 386 399 88 83 183 131 64 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
140 
disease_progression 
H-positive risk:  695 643 83 1164 399 87 1114 391 131 48 180 65 
H-negative risk:  643 695 1114 1164 391 399 87 83 180 131 65 48 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
141 
disease_progression 
H-positive risk:  694 639 83 1156 408 86 1118 393 130 49 179 65 
H-negative risk:  639 694 1118 1156 393 408 86 83 179 130 65 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
142 
disease_progression 
H-positive risk:  699 645 86 1150 401 86 1119 391 129 50 175 69 
H-negative risk:  645 699 1119 1150 391 401 86 86 175 129 69 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
143 
disease_progression 
H-positive risk:  701 643 88 1144 405 85 1118 388 133 53 174 68 
H-negative risk:  643 701 1118 1144 388 405 85 88 174 133 68 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
144 
disease_progression 
H-positive risk:  699 641 88 1156 404 84 1118 387 133 53 175 62 
H-negative risk:  641 699 1118 1156 387 404 84 88 175 133 62 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
145 
disease_progression 
H-positive risk:  696 637 91 1156 403 87 1121 387 136 53 173 60 
H-negative risk:  637 696 1121 1156 387 403 87 91 173 136 60 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
97 new agents 
146 
disease_progression 
H-positive risk:  694 635 89 1155 410 87 1111 394 135 55 174 61 
H-negative risk:  635 694 1111 1155 394 410 87 89 174 135 61 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
147 
disease_progression 
H-positive risk:  680 640 94 1142 414 88 1115 397 137 57 174 62 
H-negative risk:  640 680 1115 1142 397 414 88 94 174 137 62 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 73 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
148 
disease_progression 
H-positive risk:  678 639 93 1145 410 89 1119 391 138 59 177 62 
H-negative risk:  639 678 1119 1145 391 410 89 93 177 138 62 59 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
149 
disease_progression 
H-positive risk:  683 636 95 1142 407 90 1120 392 137 60 177 61 
H-negative risk:  636 683 1120 1142 392 407 90 95 177 137 61 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
150 
disease_progression 
H-positive risk:  687 641 94 1151 397 91 1124 383 137 57 177 61 
H-negative risk:  641 687 1124 1151 383 397 91 94 177 137 61 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
151 
disease_progression 
H-positive risk:  680 634 95 1155 401 92 1128 383 137 58 175 62 
H-negative risk:  634 680 1128 1155 383 401 92 95 175 137 62 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
152 
disease_progression 
H-positive risk:  675 634 97 1157 395 92 1134 383 139 57 177 60 
H-negative risk:  634 675 1134 1157 383 395 92 97 177 139 60 57 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 72 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
153 
disease_progression 
H-positive risk:  671 631 96 1171 396 93 1130 378 137 60 179 58 
H-negative risk:  631 671 1130 1171 378 396 93 96 179 137 58 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
154 
disease_progression 
H-positive risk:  678 633 97 1175 392 95 1125 372 137 60 176 60 
H-negative risk:  633 678 1125 1175 372 392 95 97 176 137 60 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
155 
disease_progression 
H-positive risk:  681 630 97 1187 389 92 1114 377 136 61 176 60 
H-negative risk:  630 681 1114 1187 377 389 92 97 176 136 60 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
156 
disease_progression 
H-positive risk:  680 630 96 1184 389 92 1112 379 136 62 180 60 
H-negative risk:  630 680 1112 1184 379 389 92 96 180 136 60 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
157 
disease_progression 
H-positive risk:  675 634 99 1185 387 94 1108 382 137 61 178 60 
H-negative risk:  634 675 1108 1185 382 387 94 99 178 137 60 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 73 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
158 
disease_progression 
H-positive risk:  670 634 98 1179 387 94 1108 392 140 57 177 64 
H-negative risk:  634 670 1108 1179 392 387 94 98 177 140 64 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
101 new agents 
159 
disease_progression 
H-positive risk:  671 631 98 1183 378 95 1130 384 137 58 176 59 
H-negative risk:  631 671 1130 1183 384 378 95 98 176 137 59 58 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
160 
disease_progression 
H-positive risk:  669 637 98 1174 378 95 1129 386 139 58 174 63 
H-negative risk:  637 669 1129 1174 386 378 95 98 174 139 63 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
161 
disease_progression 
H-positive risk:  669 648 97 1158 383 96 1123 389 139 59 174 65 
H-negative risk:  648 669 1123 1158 389 383 96 97 174 139 65 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
162 
disease_progression 
H-positive risk:  666 646 98 1162 386 95 1127 388 141 56 173 62 
H-negative risk:  646 666 1127 1162 388 386 95 98 173 141 62 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
163 
disease_progression 
H-positive risk:  665 647 98 1162 390 92 1130 384 140 58 173 61 
H-negative risk:  647 665 1130 1162 384 390 92 98 173 140 61 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
164 
disease_progression 
H-positive risk:  661 653 98 1161 390 93 1128 387 136 55 176 62 
H-negative risk:  653 661 1128 1161 387 390 93 98 176 136 62 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
165 
disease_progression 
H-positive risk:  658 653 95 1158 391 94 1138 389 131 55 176 62 
H-negative risk:  653 658 1138 1158 389 391 94 95 176 131 62 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
90 new agents 
166 
disease_progression 
H-positive risk:  663 649 93 1168 382 94 1140 382 133 55 178 63 
H-negative risk:  649 663 1140 1168 382 382 94 93 178 133 63 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
56 new agents 
167 
disease_progression 
H-positive risk:  666 649 94 1153 385 94 1143 388 134 55 178 61 
H-negative risk:  649 666 1143 1153 388 385 94 94 178 134 61 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
168 
disease_progression 
H-positive risk:  668 654 93 1151 378 95 1144 394 134 50 177 62 
H-negative risk:  654 668 1144 1151 394 378 95 93 177 134 62 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
169 
disease_progression 
H-positive risk:  668 653 92 1154 382 93 1147 390 138 49 174 60 
H-negative risk:  653 668 1147 1154 390 382 93 92 174 138 60 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
94 new agents 
170 
disease_progression 
H-positive risk:  670 651 92 1128 399 92 1146 395 143 48 173 63 
H-negative risk:  651 670 1146 1128 395 399 92 92 173 143 63 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
171 
disease_progression 
H-positive risk:  667 651 93 1126 398 90 1150 396 141 50 172 66 
H-negative risk:  651 667 1150 1126 396 398 90 93 172 141 66 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
172 
disease_progression 
H-positive risk:  675 643 90 1130 392 87 1152 397 143 50 175 66 
H-negative risk:  643 675 1152 1130 397 392 87 90 175 143 66 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
173 
disease_progression 
H-positive risk:  681 640 89 1131 394 87 1151 394 142 50 174 67 
H-negative risk:  640 681 1151 1131 394 394 87 89 174 142 67 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
174 
disease_progression 
H-positive risk:  676 639 88 1140 387 87 1157 394 139 49 176 68 
H-negative risk:  639 676 1157 1140 394 387 87 88 176 139 68 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
175 
disease_progression 
H-positive risk:  681 643 88 1146 379 88 1148 388 141 50 179 69 
H-negative risk:  643 681 1148 1146 388 379 88 88 179 141 69 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
176 
disease_progression 
H-positive risk:  692 644 89 1145 370 89 1142 392 140 50 176 71 
H-negative risk:  644 692 1142 1145 392 370 89 89 176 140 71 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
177 
disease_progression 
H-positive risk:  698 650 87 1144 368 91 1134 392 139 50 175 72 
H-negative risk:  650 698 1134 1144 392 368 91 87 175 139 72 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
178 
disease_progression 
H-positive risk:  693 646 89 1148 373 90 1141 391 138 50 171 70 
H-negative risk:  646 693 1141 1148 391 373 90 89 171 138 70 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
179 
disease_progression 
H-positive risk:  703 652 88 1145 374 89 1138 387 139 48 169 68 
H-negative risk:  652 703 1138 1145 387 374 89 88 169 139 68 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
180 
disease_progression 
H-positive risk:  695 659 89 1144 377 92 1141 384 139 47 167 66 
H-negative risk:  659 695 1141 1144 384 377 92 89 167 139 66 47 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
181 
disease_progression 
H-positive risk:  690 660 88 1154 375 95 1139 384 135 47 167 66 
H-negative risk:  660 690 1139 1154 384 375 95 88 167 135 66 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
182 
disease_progression 
H-positive risk:  693 659 85 1135 385 95 1126 402 135 51 167 67 
H-negative risk:  659 693 1126 1135 402 385 95 85 167 135 67 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
183 
disease_progression 
H-positive risk:  685 659 88 1130 390 89 1134 399 140 54 163 69 
H-negative risk:  659 685 1134 1130 399 390 89 88 163 140 69 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
89 new agents 
184 
disease_progression 
H-positive risk:  683 666 90 1129 381 95 1135 395 140 55 160 71 
H-negative risk:  666 683 1135 1129 395 381 95 90 160 140 71 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
185 
disease_progression 
H-positive risk:  677 662 92 1133 382 90 1137 397 143 55 161 71 
H-negative risk:  662 677 1137 1133 397 382 90 92 161 143 71 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
186 
disease_progression 
H-positive risk:  673 658 94 1135 384 90 1139 398 143 56 161 69 
H-negative risk:  658 673 1139 1135 398 384 90 94 161 143 69 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
187 
disease_progression 
H-positive risk:  679 658 94 1133 386 93 1121 407 144 55 160 70 
H-negative risk:  658 679 1121 1133 407 386 93 94 160 144 70 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
188 
disease_progression 
H-positive risk:  681 659 93 1136 384 90 1115 412 146 54 159 71 
H-negative risk:  659 681 1115 1136 412 384 90 93 159 146 71 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
54 new agents 
189 
disease_progression 
H-positive risk:  678 655 95 1144 387 90 1114 409 148 53 155 72 
H-negative risk:  655 678 1114 1144 409 387 90 95 155 148 72 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
190 
disease_progression 
H-positive risk:  678 641 97 1146 388 90 1119 412 149 51 155 74 
H-negative risk:  641 678 1119 1146 412 388 90 97 155 149 74 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
191 
disease_progression 
H-positive risk:  678 642 100 1144 390 86 1119 410 150 52 156 73 
H-negative risk:  642 678 1119 1144 410 390 86 100 156 150 73 52 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
192 
disease_progression 
H-positive risk:  686 636 101 1146 401 82 1107 413 152 49 154 73 
H-negative risk:  636 686 1107 1146 413 401 82 101 154 152 73 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
193 
disease_progression 
H-positive risk:  680 635 101 1152 405 84 1103 409 152 49 157 73 
H-negative risk:  635 680 1103 1152 409 405 84 101 157 152 73 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
98 new agents 
194 
disease_progression 
H-positive risk:  696 636 101 1139 411 87 1085 422 144 50 158 71 
H-negative risk:  636 696 1085 1139 422 411 87 101 158 144 71 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
195 
disease_progression 
H-positive risk:  703 638 98 1145 415 87 1086 413 140 49 159 67 
H-negative risk:  638 703 1086 1145 413 415 87 98 159 140 67 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
196 
disease_progression 
H-positive risk:  699 635 99 1140 430 87 1085 413 141 46 157 68 
H-negative risk:  635 699 1085 1140 413 430 87 99 157 141 68 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
197 
disease_progression 
H-positive risk:  701 640 99 1136 432 85 1083 415 139 47 157 66 
H-negative risk:  640 701 1083 1136 415 432 85 99 157 139 66 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
198 
disease_progression 
H-positive risk:  701 637 100 1143 432 85 1086 412 138 47 152 67 
H-negative risk:  637 701 1086 1143 412 432 85 100 152 138 67 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
199 
disease_progression 
H-positive risk:  697 626 100 1145 435 86 1098 404 140 46 157 66 
H-negative risk:  626 697 1098 1145 404 435 86 100 157 140 66 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
92 new agents 
200 
disease_progression 
H-positive risk:  704 628 98 1145 432 83 1098 402 141 46 160 63 
H-negative risk:  628 704 1098 1145 402 432 83 98 160 141 63 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
201 
disease_progression 
H-positive risk:  699 632 99 1148 429 81 1103 400 141 46 157 65 
H-negative risk:  632 699 1103 1148 400 429 81 99 157 141 65 46 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
202 
disease_progression 
H-positive risk:  704 635 97 1147 423 82 1103 399 141 44 159 66 
H-negative risk:  635 704 1103 1147 399 423 82 97 159 141 66 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
203 
disease_progression 
H-positive risk:  707 627 97 1149 424 85 1102 399 143 44 159 64 
H-negative risk:  627 707 1102 1149 399 424 85 97 159 143 64 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
204 
disease_progression 
H-positive risk:  709 622 99 1148 426 85 1101 401 144 45 156 64 
H-negative risk:  622 709 1101 1148 401 426 85 99 156 144 64 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
205 
disease_progression 
H-positive risk:  711 622 99 1154 414 82 1103 397 143 49 161 65 
H-negative risk:  622 711 1103 1154 397 414 82 99 161 143 65 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
206 
disease_progression 
H-positive risk:  712 624 95 1142 416 84 1102 401 141 52 159 72 
H-negative risk:  624 712 1102 1142 401 416 84 95 159 141 72 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
207 
disease_progression 
H-positive risk:  706 629 97 1131 421 85 1102 404 139 53 161 72 
H-negative risk:  629 706 1102 1131 404 421 85 97 161 139 72 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
208 
disease_progression 
H-positive risk:  707 625 95 1128 428 86 1099 409 142 52 160 69 
H-negative risk:  625 707 1099 1128 409 428 86 95 160 142 69 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
209 
disease_progression 
H-positive risk:  703 631 97 1121 426 88 1105 404 144 53 159 69 
H-negative risk:  631 703 1105 1121 404 426 88 97 159 144 69 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
210 
disease_progression 
H-positive risk:  703 634 96 1122 427 89 1101 400 145 54 161 68 
H-negative risk:  634 703 1101 1122 400 427 89 96 161 145 68 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
211 
disease_progression 
H-positive risk:  706 629 98 1118 431 91 1090 408 145 52 163 69 
H-negative risk:  629 706 1090 1118 408 431 91 98 163 145 69 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
212 
disease_progression 
H-positive risk:  696 628 99 1115 434 89 1106 406 145 55 158 69 
H-negative risk:  628 696 1106 1115 406 434 89 99 158 145 69 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
213 
disease_progression 
H-positive risk:  693 624 96 1113 442 89 1108 410 147 55 154 69 
H-negative risk:  624 693 1108 1113 410 442 89 96 154 147 69 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
214 
disease_progression 
H-positive risk:  702 628 96 1103 443 87 1105 414 147 54 153 68 
H-negative risk:  628 702 1105 1103 414 443 87 96 153 147 68 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
215 
disease_progression 
H-positive risk:  700 626 94 1108 448 87 1112 404 148 54 154 65 
H-negative risk:  626 700 1112 1108 404 448 87 94 154 148 65 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
216 
disease_progression 
H-positive risk:  696 620 96 1119 446 89 1114 407 148 51 150 64 
H-negative risk:  620 696 1114 1119 407 446 89 96 150 148 64 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
217 
disease_progression 
H-positive risk:  693 627 95 1110 460 88 1101 411 148 52 152 63 
H-negative risk:  627 693 1101 1110 411 460 88 95 152 148 63 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
218 
disease_progression 
H-positive risk:  688 622 96 1104 460 89 1110 407 151 59 149 65 
H-negative risk:  622 688 1110 1104 407 460 89 96 149 151 65 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
219 
disease_progression 
H-positive risk:  692 634 95 1110 451 88 1107 408 146 59 147 63 
H-negative risk:  634 692 1107 1110 408 451 88 95 147 146 63 59 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
220 
disease_progression 
H-positive risk:  693 627 98 1109 455 92 1107 409 143 59 147 61 
H-negative risk:  627 693 1107 1109 409 455 92 98 147 143 61 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
94 new agents 
221 
disease_progression 
H-positive risk:  697 635 99 1107 449 90 1108 405 143 62 147 58 
H-negative risk:  635 697 1108 1107 405 449 90 99 147 143 58 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
222 
disease_progression 
H-positive risk:  694 631 101 1104 444 89 1115 406 144 63 148 61 
H-negative risk:  631 694 1115 1104 406 444 89 101 148 144 61 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
223 
disease_progression 
H-positive risk:  692 633 102 1110 440 90 1110 404 144 63 150 62 
H-negative risk:  633 692 1110 1110 404 440 90 102 150 144 62 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
224 
disease_progression 
H-positive risk:  695 631 104 1107 438 90 1109 408 143 63 151 61 
H-negative risk:  631 695 1109 1107 408 438 90 104 151 143 61 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
225 
disease_progression 
H-positive risk:  694 640 102 1102 439 91 1101 414 145 64 149 59 
H-negative risk:  640 694 1101 1102 414 439 91 102 149 145 59 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
226 
disease_progression 
H-positive risk:  705 643 98 1096 431 93 1099 417 144 64 151 59 
H-negative risk:  643 705 1099 1096 417 431 93 98 151 144 59 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
93 new agents 
227 
disease_progression 
H-positive risk:  706 651 96 1105 425 93 1095 418 143 62 148 58 
H-negative risk:  651 706 1095 1105 418 425 93 96 148 143 58 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
228 
disease_progression 
H-positive risk:  706 653 98 1106 427 93 1104 409 144 58 146 56 
H-negative risk:  653 706 1104 1106 409 427 93 98 146 144 56 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
229 
disease_progression 
H-positive risk:  716 651 101 1091 442 93 1084 422 140 59 146 55 
H-negative risk:  651 716 1084 1091 422 442 93 101 146 140 55 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
91 new agents 
230 
disease_progression 
H-positive risk:  717 653 100 1103 436 91 1080 421 142 57 145 55 
H-negative risk:  653 717 1080 1103 421 436 91 100 145 142 55 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
231 
disease_progression 
H-positive risk:  724 653 97 1102 437 95 1075 420 138 56 151 52 
H-negative risk:  653 724 1075 1102 420 437 95 97 151 138 52 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
232 
disease_progression 
H-positive risk:  731 649 99 1103 442 95 1064 421 137 54 152 53 
H-negative risk:  649 731 1064 1103 421 442 95 99 152 137 53 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 93 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
233 
disease_progression 
H-positive risk:  730 653 100 1106 443 97 1065 410 137 55 148 56 
H-negative risk:  653 730 1065 1106 410 443 97 100 148 137 56 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
234 
disease_progression 
H-positive risk:  732 656 103 1108 451 96 1067 405 135 52 144 51 
H-negative risk:  656 732 1067 1108 405 451 96 103 144 135 51 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
57 new agents 
235 
disease_progression 
H-positive risk:  727 656 103 1106 449 96 1067 413 136 53 141 53 
H-negative risk:  656 727 1067 1106 413 449 96 103 141 136 53 53 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
236 
disease_progression 
H-positive risk:  723 647 105 1107 450 94 1077 413 139 53 142 50 
H-negative risk:  647 723 1077 1107 413 450 94 105 142 139 50 53 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
237 
disease_progression 
H-positive risk:  726 640 109 1114 445 94 1076 413 139 52 142 50 
H-negative risk:  640 726 1076 1114 413 445 94 109 142 139 50 52 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
238 
disease_progression 
H-positive risk:  719 646 110 1111 444 95 1076 412 141 52 144 50 
H-negative risk:  646 719 1076 1111 412 444 95 110 144 141 50 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
239 
disease_progression 
H-positive risk:  717 644 111 1111 447 95 1073 413 138 52 149 50 
H-negative risk:  644 717 1073 1111 413 447 95 111 149 138 50 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
240 
disease_progression 
H-positive risk:  718 654 111 1106 446 96 1080 402 137 52 147 51 
H-negative risk:  654 718 1080 1106 402 446 96 111 147 137 51 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
241 
disease_progression 
H-positive risk:  722 653 109 1101 451 99 1060 415 135 55 149 51 
H-negative risk:  653 722 1060 1101 415 451 99 109 149 135 51 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
242 
disease_progression 
H-positive risk:  726 644 108 1123 443 99 1050 415 138 53 150 51 
H-negative risk:  644 726 1050 1123 415 443 99 108 150 138 51 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
243 
disease_progression 
H-positive risk:  724 639 108 1135 447 101 1056 405 134 54 151 46 
H-negative risk:  639 724 1056 1135 405 447 101 108 151 134 46 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
244 
disease_progression 
H-positive risk:  730 645 105 1123 447 101 1051 410 132 54 157 45 
H-negative risk:  645 730 1051 1123 410 447 101 105 157 132 45 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
245 
disease_progression 
H-positive risk:  733 654 102 1117 444 99 1053 413 130 53 155 47 
H-negative risk:  654 733 1053 1117 413 444 99 102 155 130 47 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
246 
disease_progression 
H-positive risk:  735 655 99 1121 440 99 1046 418 131 48 159 49 
H-negative risk:  655 735 1046 1121 418 440 99 99 159 131 49 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 86 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
247 
disease_progression 
H-positive risk:  741 659 97 1118 429 100 1043 424 133 48 160 48 
H-negative risk:  659 741 1043 1118 424 429 100 97 160 133 48 48 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
248 
disease_progression 
H-positive risk:  738 661 96 1119 435 100 1047 417 132 47 161 47 
H-negative risk:  661 738 1047 1119 417 435 100 96 161 132 47 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
249 
disease_progression 
H-positive risk:  739 662 95 1115 435 97 1044 418 137 46 163 49 
H-negative risk:  662 739 1044 1115 418 435 97 95 163 137 49 46 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
250 
disease_progression 
H-positive risk:  734 662 92 1117 431 97 1049 419 137 47 166 49 
H-negative risk:  662 734 1049 1117 419 431 97 92 166 137 49 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
251 
disease_progression 
H-positive risk:  730 657 93 1123 426 97 1052 427 137 46 166 46 
H-negative risk:  657 730 1052 1123 427 426 97 93 166 137 46 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
252 
disease_progression 
H-positive risk:  733 653 93 1130 421 97 1051 430 135 46 165 46 
H-negative risk:  653 733 1051 1130 430 421 97 93 165 135 46 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
253 
disease_progression 
H-positive risk:  732 655 93 1127 426 96 1044 432 138 46 163 48 
H-negative risk:  655 732 1044 1127 432 426 96 93 163 138 48 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
104 new agents 
254 
disease_progression 
H-positive risk:  735 648 96 1125 431 99 1042 422 141 43 168 50 
H-negative risk:  648 735 1042 1125 422 431 99 96 168 141 50 43 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
255 
disease_progression 
H-positive risk:  729 646 96 1125 433 95 1047 421 144 44 168 52 
H-negative risk:  646 729 1047 1125 421 433 95 96 168 144 52 44 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
256 
disease_progression 
H-positive risk:  728 641 97 1123 435 94 1047 423 146 47 165 54 
H-negative risk:  641 728 1047 1123 423 435 94 97 165 146 54 47 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
257 
disease_progression 
H-positive risk:  729 640 98 1125 435 92 1042 423 146 47 166 57 
H-negative risk:  640 729 1042 1125 423 435 92 98 166 146 57 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
258 
disease_progression 
H-positive risk:  727 639 98 1123 434 92 1046 425 146 48 165 57 
H-negative risk:  639 727 1046 1123 425 434 92 98 165 146 57 48 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
259 
disease_progression 
H-positive risk:  726 637 98 1124 431 91 1054 419 149 49 165 57 
H-negative risk:  637 726 1054 1124 419 431 91 98 165 149 57 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
260 
disease_progression 
H-positive risk:  726 641 101 1128 420 97 1054 415 148 50 162 58 
H-negative risk:  641 726 1054 1128 415 420 97 101 162 148 58 50 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
261 
disease_progression 
H-positive risk:  725 638 100 1125 418 96 1051 428 151 48 165 55 
H-negative risk:  638 725 1051 1125 428 418 96 100 165 151 55 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
262 
disease_progression 
H-positive risk:  725 633 97 1116 424 97 1058 429 153 47 167 54 
H-negative risk:  633 725 1058 1116 429 424 97 97 167 153 54 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 68 29 

clinical_engagement 
diagnosis 
demography 
81 new agents 
263 
disease_progression 
H-positive risk:  721 634 96 1121 418 95 1058 436 151 46 171 53 
H-negative risk:  634 721 1058 1121 436 418 95 96 171 151 53 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
264 
disease_progression 
H-positive risk:  721 633 99 1125 421 95 1049 436 151 44 172 54 
H-negative risk:  633 721 1049 1125 436 421 95 99 172 151 54 44 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
64 new agents 
265 
disease_progression 
H-positive risk:  716 639 100 1125 417 96 1053 435 149 48 170 52 
H-negative risk:  639 716 1053 1125 435 417 96 100 170 149 52 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
266 
disease_progression 
H-positive risk:  707 640 102 1131 419 98 1056 431 147 49 166 54 
H-negative risk:  640 707 1056 1131 431 419 98 102 166 147 54 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
87 new agents 
267 
disease_progression 
H-positive risk:  703 640 99 1135 415 100 1060 433 144 51 165 55 
H-negative risk:  640 703 1060 1135 433 415 100 99 165 144 55 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 71 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
268 
disease_progression 
H-positive risk:  699 644 101 1133 410 98 1067 434 143 51 162 58 
H-negative risk:  644 699 1067 1133 434 410 98 101 162 143 58 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 67 29 

clinical_engagement 
diagnosis 
demography 
90 new agents 
269 
disease_progression 
H-positive risk:  703 644 101 1132 412 96 1076 423 142 50 161 60 
H-negative risk:  644 703 1076 1132 423 412 96 101 161 142 60 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
270 
disease_progression 
H-positive risk:  698 653 100 1126 411 92 1079 424 143 52 158 64 
H-negative risk:  653 698 1079 1126 424 411 92 100 158 143 64 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 66 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
271 
disease_progression 
H-positive risk:  696 650 101 1129 405 94 1082 420 147 50 161 65 
H-negative risk:  650 696 1082 1129 420 405 94 101 161 147 65 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 65 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
272 
disease_progression 
H-positive risk:  699 657 101 1119 409 95 1080 418 145 51 162 64 
H-negative risk:  657 699 1080 1119 418 409 95 101 162 145 64 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 65 33 

clinical_engagement 
diagnosis 
demography 
87 new agents 
273 
disease_progression 
H-positive risk:  706 651 102 1122 415 95 1077 407 146 53 162 64 
H-negative risk:  651 706 1077 1122 407 415 95 102 162 146 64 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 67 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
274 
disease_progression 
H-positive risk:  706 654 102 1121 413 95 1070 409 148 56 162 64 
H-negative risk:  654 706 1070 1121 409 413 95 102 162 148 64 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
92 new agents 
275 
disease_progression 
H-positive risk:  697 659 101 1126 413 94 1067 408 151 58 163 63 
H-negative risk:  659 697 1067 1126 408 413 94 101 163 151 63 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
276 
disease_progression 
H-positive risk:  694 659 101 1129 410 93 1062 413 155 58 162 64 
H-negative risk:  659 694 1062 1129 413 410 93 101 162 155 64 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
75 new agents 
277 
disease_progression 
H-positive risk:  690 659 98 1135 410 93 1058 415 155 58 167 62 
H-negative risk:  659 690 1058 1135 415 410 93 98 167 155 62 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
278 
disease_progression 
H-positive risk:  686 659 98 1129 411 89 1065 415 158 58 167 65 
H-negative risk:  659 686 1065 1129 415 411 89 98 167 158 65 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 75 31 

clinical_engagement 
diagnosis 
demography 
68 new agents 
279 
disease_progression 
H-positive risk:  684 658 96 1128 418 88 1066 415 159 56 168 64 
H-negative risk:  658 684 1066 1128 415 418 88 96 168 159 64 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
77 new agents 
280 
disease_progression 
H-positive risk:  680 664 95 1126 420 87 1058 420 160 56 170 64 
H-negative risk:  664 680 1058 1126 420 420 87 95 170 160 64 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
281 
disease_progression 
H-positive risk:  670 671 94 1126 417 87 1064 421 159 56 171 64 
H-negative risk:  671 670 1064 1126 421 417 87 94 171 159 64 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
282 
disease_progression 
H-positive risk:  675 667 95 1135 408 85 1063 423 161 56 169 63 
H-negative risk:  667 675 1063 1135 423 408 85 95 169 161 63 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
83 new agents 
283 
disease_progression 
H-positive risk:  676 671 93 1137 397 87 1065 423 161 55 172 63 
H-negative risk:  671 676 1065 1137 423 397 87 93 172 161 63 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
284 
disease_progression 
H-positive risk:  679 662 91 1145 397 87 1072 419 162 54 170 62 
H-negative risk:  662 679 1072 1145 419 397 87 91 170 162 62 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
66 new agents 
285 
disease_progression 
H-positive risk:  677 671 92 1129 398 89 1072 425 161 55 170 61 
H-negative risk:  671 677 1072 1129 425 398 89 92 170 161 61 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 84 31 

clinical_engagement 
diagnosis 
demography 
92 new agents 
286 
disease_progression 
H-positive risk:  674 686 95 1126 393 90 1066 424 164 54 168 60 
H-negative risk:  686 674 1066 1126 424 393 90 95 168 164 60 54 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
78 new agents 
287 
disease_progression 
H-positive risk:  678 687 95 1116 393 92 1071 420 159 57 168 64 
H-negative risk:  687 678 1071 1116 420 393 92 95 168 159 64 57 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
288 
disease_progression 
H-positive risk:  681 695 95 1116 391 91 1064 415 162 58 166 66 
H-negative risk:  695 681 1064 1116 415 391 91 95 166 162 66 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 86 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
289 
disease_progression 
H-positive risk:  674 694 95 1120 385 91 1072 414 166 57 167 65 
H-negative risk:  694 674 1072 1120 414 385 91 95 167 166 65 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
290 
disease_progression 
H-positive risk:  665 697 96 1123 384 90 1086 399 164 62 168 66 
H-negative risk:  697 665 1086 1123 399 384 90 96 168 164 66 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
291 
disease_progression 
H-positive risk:  675 688 95 1128 394 89 1077 399 164 60 166 65 
H-negative risk:  688 675 1077 1128 399 394 89 95 166 164 65 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
292 
disease_progression 
H-positive risk:  678 695 94 1129 395 86 1074 396 164 61 164 64 
H-negative risk:  695 678 1074 1129 396 395 86 94 164 164 64 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
86 new agents 
293 
disease_progression 
H-positive risk:  667 695 91 1133 391 86 1084 399 163 63 168 60 
H-negative risk:  695 667 1084 1133 399 391 86 91 168 163 60 63 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
294 
disease_progression 
H-positive risk:  660 700 90 1128 383 89 1089 407 163 64 166 61 
H-negative risk:  700 660 1089 1128 407 383 89 90 166 163 61 64 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
295 
disease_progression 
H-positive risk:  658 694 92 1135 379 86 1091 412 166 63 165 59 
H-negative risk:  694 658 1091 1135 412 379 86 92 165 166 59 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
296 
disease_progression 
H-positive risk:  657 695 91 1141 378 83 1094 409 167 60 163 62 
H-negative risk:  695 657 1094 1141 409 378 83 91 163 167 62 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
297 
disease_progression 
H-positive risk:  655 697 94 1136 380 82 1107 403 167 59 161 59 
H-negative risk:  697 655 1107 1136 403 380 82 94 161 167 59 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
298 
disease_progression 
H-positive risk:  649 689 94 1143 375 76 1115 408 172 59 160 60 
H-negative risk:  689 649 1115 1143 408 375 76 94 160 172 60 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
299 
disease_progression 
H-positive risk:  656 689 94 1136 375 80 1112 402 173 58 164 61 
H-negative risk:  689 656 1112 1136 402 375 80 94 164 173 61 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
300 
disease_progression 
H-positive risk:  653 686 93 1129 377 80 1116 402 176 58 167 63 
H-negative risk:  686 653 1116 1129 402 377 80 93 167 176 63 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
301 
disease_progression 
H-positive risk:  653 685 91 1125 384 81 1109 402 177 60 170 63 
H-negative risk:  685 653 1109 1125 402 384 81 91 170 177 63 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
302 
disease_progression 
H-positive risk:  652 682 90 1125 381 81 1115 401 179 59 169 66 
H-negative risk:  682 652 1115 1125 401 381 81 90 169 179 66 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
303 
disease_progression 
H-positive risk:  656 681 91 1133 371 79 1117 399 182 56 171 64 
H-negative risk:  681 656 1117 1133 399 371 79 91 171 182 64 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
304 
disease_progression 
H-positive risk:  658 689 88 1126 366 77 1110 408 183 57 174 64 
H-negative risk:  689 658 1110 1126 408 366 77 88 174 183 64 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
305 
disease_progression 
H-positive risk:  652 689 89 1133 365 77 1108 413 183 53 173 65 
H-negative risk:  689 652 1108 1133 413 365 77 89 173 183 65 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
306 
disease_progression 
H-positive risk:  660 680 89 1121 369 79 1114 418 182 52 170 66 
H-negative risk:  680 660 1114 1121 418 369 79 89 170 182 66 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
307 
disease_progression 
H-positive risk:  655 677 89 1119 372 77 1128 412 185 52 167 67 
H-negative risk:  677 655 1128 1119 412 372 77 89 167 185 67 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
308 
disease_progression 
H-positive risk:  659 669 91 1120 373 76 1130 412 186 54 164 66 
H-negative risk:  669 659 1130 1120 412 373 76 91 164 186 66 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
309 
disease_progression 
H-positive risk:  662 673 92 1123 370 77 1120 411 184 57 167 64 
H-negative risk:  673 662 1120 1123 411 370 77 92 167 184 64 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
310 
disease_progression 
H-positive risk:  658 670 94 1120 374 81 1129 406 182 57 166 63 
H-negative risk:  670 658 1129 1120 406 374 81 94 166 182 63 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
311 
disease_progression 
H-positive risk:  658 673 96 1113 378 79 1120 410 183 59 166 65 
H-negative risk:  673 658 1120 1113 410 378 79 96 166 183 65 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
74 new agents 
312 
disease_progression 
H-positive risk:  657 675 95 1111 384 81 1116 411 181 59 165 65 
H-negative risk:  675 657 1116 1111 411 384 81 95 165 181 65 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
313 
disease_progression 
H-positive risk:  659 677 97 1108 382 81 1122 405 180 59 165 65 
H-negative risk:  677 659 1122 1108 405 382 81 97 165 180 65 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
314 
disease_progression 
H-positive risk:  663 686 99 1106 369 82 1120 409 179 59 164 64 
H-negative risk:  686 663 1120 1106 409 369 82 99 164 179 64 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
315 
disease_progression 
H-positive risk:  658 690 99 1105 373 79 1124 402 185 57 165 63 
H-negative risk:  690 658 1124 1105 402 373 79 99 165 185 63 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
316 
disease_progression 
H-positive risk:  657 691 99 1104 379 79 1122 403 182 57 163 64 
H-negative risk:  691 657 1122 1104 403 379 79 99 163 182 64 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
67 new agents 
317 
disease_progression 
H-positive risk:  656 693 99 1094 381 79 1121 411 184 56 162 64 
H-negative risk:  693 656 1121 1094 411 381 79 99 162 184 64 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
79 new agents 
318 
disease_progression 
H-positive risk:  653 692 98 1105 376 78 1116 413 183 56 164 66 
H-negative risk:  692 653 1116 1105 413 376 78 98 164 183 66 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
94 new agents 
319 
disease_progression 
H-positive risk:  657 693 102 1098 389 78 1112 412 180 58 156 65 
H-negative risk:  693 657 1112 1098 412 389 78 102 156 180 65 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 89 14 

clinical_engagement 
diagnosis 
demography 
64 new agents 
320 
disease_progression 
H-positive risk:  653 691 104 1095 393 80 1117 408 180 61 151 67 
H-negative risk:  691 653 1117 1095 408 393 80 104 151 180 67 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 88 14 

clinical_engagement 
diagnosis 
demography 
93 new agents 
321 
disease_progression 
H-positive risk:  661 701 100 1092 398 81 1108 405 179 57 153 65 
H-negative risk:  701 661 1108 1092 405 398 81 100 153 179 65 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
322 
disease_progression 
H-positive risk:  664 698 100 1093 393 83 1101 410 178 60 155 65 
H-negative risk:  698 664 1101 1093 410 393 83 100 155 178 65 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
323 
disease_progression 
H-positive risk:  672 701 99 1095 391 82 1092 408 180 59 155 66 
H-negative risk:  701 672 1092 1095 408 391 82 99 155 180 66 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
324 
disease_progression 
H-positive risk:  670 700 99 1091 397 82 1095 407 180 58 157 64 
H-negative risk:  700 670 1095 1091 407 397 82 99 157 180 64 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
325 
disease_progression 
H-positive risk:  676 695 99 1091 400 81 1081 422 176 61 157 61 
H-negative risk:  695 676 1081 1091 422 400 81 99 157 176 61 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
326 
disease_progression 
H-positive risk:  674 687 98 1093 409 85 1087 416 173 61 156 61 
H-negative risk:  687 674 1087 1093 416 409 85 98 156 173 61 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
99 new agents 
327 
disease_progression 
H-positive risk:  678 687 99 1087 412 86 1082 420 172 62 155 60 
H-negative risk:  687 678 1082 1087 420 412 86 99 155 172 60 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
328 
disease_progression 
H-positive risk:  687 692 102 1089 410 88 1078 414 174 59 150 57 
H-negative risk:  692 687 1078 1089 414 410 88 102 150 174 57 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
329 
disease_progression 
H-positive risk:  697 688 100 1093 406 90 1071 415 169 62 153 56 
H-negative risk:  688 697 1071 1093 415 406 90 100 153 169 56 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
330 
disease_progression 
H-positive risk:  697 688 102 1096 410 92 1055 422 168 61 153 56 
H-negative risk:  688 697 1055 1096 422 410 92 102 153 168 56 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
331 
disease_progression 
H-positive risk:  690 686 103 1092 411 91 1064 428 165 60 156 54 
H-negative risk:  686 690 1064 1092 428 411 91 103 156 165 54 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
332 
disease_progression 
H-positive risk:  699 685 101 1092 406 89 1060 427 165 59 162 55 
H-negative risk:  685 699 1060 1092 427 406 89 101 162 165 55 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
88 new agents 
333 
disease_progression 
H-positive risk:  698 682 105 1091 403 84 1064 424 168 62 164 55 
H-negative risk:  682 698 1064 1091 424 403 84 105 164 168 55 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
64 new agents 
334 
disease_progression 
H-positive risk:  698 688 104 1096 403 83 1060 420 169 63 160 56 
H-negative risk:  688 698 1060 1096 420 403 83 104 160 169 56 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
100 new agents 
335 
disease_progression 
H-positive risk:  709 685 106 1094 401 84 1062 416 168 60 157 58 
H-negative risk:  685 709 1062 1094 416 401 84 106 157 168 58 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
336 
disease_progression 
H-positive risk:  713 680 102 1087 402 82 1074 411 171 58 162 58 
H-negative risk:  680 713 1074 1087 411 402 82 102 162 171 58 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
337 
disease_progression 
H-positive risk:  708 687 102 1085 411 83 1071 410 170 59 158 56 
H-negative risk:  687 708 1071 1085 410 411 83 102 158 170 56 59 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
338 
disease_progression 
H-positive risk:  709 686 105 1083 413 87 1063 415 168 61 153 57 
H-negative risk:  686 709 1063 1083 415 413 87 105 153 168 57 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
339 
disease_progression 
H-positive risk:  706 686 106 1080 412 91 1072 413 165 59 152 58 
H-negative risk:  686 706 1072 1080 413 412 91 106 152 165 58 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
340 
disease_progression 
H-positive risk:  701 693 106 1087 406 90 1076 408 164 62 151 56 
H-negative risk:  693 701 1076 1087 408 406 90 106 151 164 56 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
341 
disease_progression 
H-positive risk:  705 691 105 1085 407 89 1077 404 167 61 153 56 
H-negative risk:  691 705 1077 1085 404 407 89 105 153 167 56 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
342 
disease_progression 
H-positive risk:  718 686 104 1084 414 89 1064 406 167 59 158 51 
H-negative risk:  686 718 1064 1084 406 414 89 104 158 167 51 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
343 
disease_progression 
H-positive risk:  716 682 103 1086 410 89 1075 402 167 62 157 51 
H-negative risk:  682 716 1075 1086 402 410 89 103 157 167 51 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
344 
disease_progression 
H-positive risk:  710 697 102 1089 408 88 1072 396 168 63 155 52 
H-negative risk:  697 710 1072 1089 396 408 88 102 155 168 52 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
345 
disease_progression 
H-positive risk:  715 694 101 1097 404 87 1071 396 169 59 154 53 
H-negative risk:  694 715 1071 1097 396 404 87 101 154 169 53 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
346 
disease_progression 
H-positive risk:  715 694 102 1095 415 87 1071 386 165 64 152 54 
H-negative risk:  694 715 1071 1095 386 415 87 102 152 165 54 64 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
347 
disease_progression 
H-positive risk:  716 689 99 1090 421 87 1080 385 164 63 150 56 
H-negative risk:  689 716 1080 1090 385 421 87 99 150 164 56 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
348 
disease_progression 
H-positive risk:  720 688 97 1095 421 88 1073 385 164 60 151 58 
H-negative risk:  688 720 1073 1095 385 421 88 97 151 164 58 60 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
349 
disease_progression 
H-positive risk:  717 685 96 1100 417 87 1066 394 167 62 150 59 
H-negative risk:  685 717 1066 1100 394 417 87 96 150 167 59 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
350 
disease_progression 
H-positive risk:  720 685 97 1089 422 84 1066 397 169 61 150 60 
H-negative risk:  685 720 1066 1089 397 422 84 97 150 169 60 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
351 
disease_progression 
H-positive risk:  718 686 100 1092 423 82 1066 395 170 61 147 60 
H-negative risk:  686 718 1066 1092 395 423 82 100 147 170 60 61 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
352 
disease_progression 
H-positive risk:  711 686 100 1085 428 81 1058 407 171 64 150 59 
H-negative risk:  686 711 1058 1085 407 428 81 100 150 171 59 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
99 new agents 
353 
disease_progression 
H-positive risk:  722 680 103 1081 424 83 1062 406 169 65 151 54 
H-negative risk:  680 722 1062 1081 406 424 83 103 151 169 54 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
354 
disease_progression 
H-positive risk:  728 682 102 1076 428 84 1054 409 167 66 152 52 
H-negative risk:  682 728 1054 1076 409 428 84 102 152 167 52 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
355 
disease_progression 
H-positive risk:  731 680 101 1063 442 86 1051 412 167 67 149 51 
H-negative risk:  680 731 1051 1063 412 442 86 101 149 167 51 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
356 
disease_progression 
H-positive risk:  732 674 100 1070 440 84 1041 422 166 69 151 51 
H-negative risk:  674 732 1041 1070 422 440 84 100 151 166 51 69 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
357 
disease_progression 
H-positive risk:  730 672 99 1072 435 83 1046 424 166 67 151 55 
H-negative risk:  672 730 1046 1072 424 435 83 99 151 166 55 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
358 
disease_progression 
H-positive risk:  734 677 100 1071 439 83 1035 425 164 70 148 54 
H-negative risk:  677 734 1035 1071 425 439 83 100 148 164 54 70 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
359 
disease_progression 
H-positive risk:  725 670 102 1078 441 82 1041 427 163 69 150 52 
H-negative risk:  670 725 1041 1078 427 441 82 102 150 163 52 69 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
360 
disease_progression 
H-positive risk:  717 664 102 1077 449 84 1042 434 163 68 148 52 
H-negative risk:  664 717 1042 1077 434 449 84 102 148 163 52 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
Time difference of 16.68234 mins
This is task 27
date
